All News

Humanigen’s Cytokine Storm Control Drug Shows Posi

Burlingame, California-based Humanigen reported positive data from its Phase Ib ZUMA-19 trial of len
Read More

Amgen Awarded Breakthrough Designation for Acquire

One month after snapping up Five Prime Therapeutics and its Phase III ready anti-FGFR2b antibody bem
Read More

Vertex Drops $900 Million to Expand Partnership wi

Vertex Pharmaceuticals has expanded its collaborative partnership with CRISPR Therapeutics to develo
Read More

Takeda reiterates commitment to supporting patient

Head of Market Access and Pricing, Takeda India, said, “Takeda is a patient-focused organisation and
Read More

RTPCR tests in use in India do not miss UK, Brazil

The release mentions that the COVID-19 virus has been mutating and various mutations have been found
Read More

Study identifies key mutations in SARS-CoV-2 ACE2

In a study published in the Nature journal Communications Biology on April 12, 2021, an internationa
Read More

Explained: What next after U.S. ex-cop’s convictio

Derek Chauvin, the former Minneapolis officer who pressed his knee against George Floyd’s neck, was
Read More


;